- ►ahajournals.org [PDF] C Curtiss, JN Cohn, T Vrobel, JA Franciosa - Circulation, 1978 - Am Heart Assoc SUMMARY In 15 patients with severe chronic left ventricular failure, plasma
renin ... (P < 0.001) and SVR from 1619 ± 148 to 1252 ± 137 dyne-sec-cm-5 (P
< 0.001). The fall in MAP and in ... SVR was significantly correlated with ... Cited by 242 - Related articles - All 2 versions
- ►ahajournals.org [PDF] TB Levine, JA Franciosa, JN Cohn - Circulation, 1980 - Am Heart Assoc SUMMARY Captopril (SQ 14,225), an oral angiotensin converting-enzyme inhibitor,
was administered to 11 patients with severe congestive heart failure (CHF). Peak
effect was observed at 1.5 hours after administra- tion. At peak effect ... Cited by 158 - Related articles - All 3 versions
JA Franciosa, LA Nordstrom, JN Cohn - JAMA, 1978 - Am Med Assoc A randomized double-blind crossover trial included 16 patients with severe
congestive heart failure who received isosorbide dinitrate or placebo for eight
weeks, and then the opposite treatment for eight more weeks. All patients ... Cited by 95 - Related articles - All 2 versions
- ►ahajournals.org [PDF] TB Levine, GS Francis, SR Goldsmith, JN … - Circulation, 1983 - Am Heart Assoc Anrinone and exercise performance in patients with chronic heart failure. Am J
Cardiol 48: 164, 1981 8. Clinical experience with amninone. In Overall Summary
for NDA Amendment. Rensselaer, New York, Sterling Winthrop Research ... Cited by 83 - Related articles - All 3 versions
RC Tarazi, EL Bravo, FM Fouad, P Omvik, RJ … - Hypertension, 1980 - Am Heart Assoc SUMMARY The effects of captopril on bemodynamic, rolmne, and neurohumoral
indices were inrestigated in 33 patients with essential hypertension or renal
arterial disease. Changes associated with treatment were studied under two ... Cited by 63 - Related articles - All 3 versions
- ►ahajournals.org [PDF] WS Aronow, M Lurie, M Turbow, K Whittaker, … - Circulation, 1979 - Am Heart Assoc WILBERT S. ARONOW, MD, MARK LURIE, MD, MARVIN TURBOW, MD, PH.D., ... KENNETH
WHITTAKER, PHARM. D., MD, STEVEN VAN CAMP, MD, ... SUMMARY The effect of the
vasodilator prazosin vs placebo on exercise duration until marked dyspnea, Cited by 60 - Related articles - All 2 versions
- ►cardiocrusaders.com [PDF] B Koifman, Y Wollman, N Bogomolny, T … - Journal of the American College of Cardiology, 1995 - Elsevier One hour of infusion of l-arginine resulted in a significant increase in stroke
volume (from 68 ± 18 ml to 76 ± 23 ml [mean ± SD], p = 0.014) and cardiac
output (from 4.07 ± 1.22 liters/min to 4.7 ± 1.42 liters/min, p = 0.006) ... Cited by 49 - Related articles - BL Direct - All 8 versions
SL Kopecky, BJ Gersh - Current Problems in Cardiology, 1987 - Elsevier The causes of dilated cardiomyopathy remain a source of intense investigation.
Accumulating evidence (much of it circumstantial) does, however, implicate a
viral etiology and perhaps altered function of the immunoregulatory system. ... Cited by 41 - Related articles - All 2 versions
- ►ahajournals.org [PDF] JA Franciosa, JN Cohn - Circulation, 1979 - Am Heart Assoc SUMMARY Resting hemodynamics improve during vasodilator administration ...
Systemic vascular resistance at peak exercise was also unchanged in both group 1
(14.1 1.6 to 11.8 ... 1.0 units) and group 2 (14.7 1.6 to 13.5 ± 1.6 ... Cited by 39 - Related articles - All 3 versions
